SARS-CoV-2 IgG Antibodies Seroprevalence and Sera Neutralizing Activity in MEXICO: A National Cross-Sectional Study during 2020

Authors

Muñoz-Medina JE, Grajales-Muñiz C, Salas-Lais AG, Fernandes-Matano L, López-Macías C, Monroy-Muñoz IE, Santos Coy-Arechavaleta A, Palomec-Nava ID, Duque-Molina C, Madera-Sandoval RL, Rivero-Arredondo V, González-Ibarra J, Alvarado-Yaah JE, Rojas-Mendoza T, Santacruz-Tinoco CE, González-Bonilla CR, Borja-Aburto VH

Journal

Microorganisms

Volume

9

Issue

4

Pages

Publication year

2021

Suggested citation

Muñoz-Medina JE, Grajales-Muñiz C, Salas-Lais AG, Fernandes-Matano L, López-Macías C, Monroy-Muñoz IE, Santos Coy-Arechavaleta A, Palomec-Nava ID, Duque-Molina C, Madera-Sandoval RL, Rivero-Arredondo V, González-Ibarra J, Alvarado-Yaah JE, Rojas-Mendoza T, Santacruz-Tinoco CE, González-Bonilla CR, Borja-Aburto VH. SARS-CoV-2 IgG Antibodies Seroprevalence and Sera Neutralizing Activity in MEXICO: A National Cross-Sectional Study during 2020. Microorganisms. 2021; 9(4).

DOI

10.3390/microorganisms9040850

PMID

33921158

Header sites

Search form

Main menu

SARS-CoV-2 IgG Antibodies Seroprevalence and Sera Neutralizing Activity in MEXICO: A National Cross-Sectional Study during 2020

Nav